Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle

Standard

Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle. / Sugawara, Koji; Zákány, Nóra; Tiede, Stephan; Purba, Talveen; Harries, Matthew; Tsuruta, Daisuke; Bíró, Tamás; Paus, Ralf.

In: EXP DERMATOL, Vol. 30, No. 4, 04.2021, p. 479-493.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Sugawara, K, Zákány, N, Tiede, S, Purba, T, Harries, M, Tsuruta, D, Bíró, T & Paus, R 2021, 'Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle', EXP DERMATOL, vol. 30, no. 4, pp. 479-493. https://doi.org/10.1111/exd.14294

APA

Sugawara, K., Zákány, N., Tiede, S., Purba, T., Harries, M., Tsuruta, D., Bíró, T., & Paus, R. (2021). Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle. EXP DERMATOL, 30(4), 479-493. https://doi.org/10.1111/exd.14294

Vancouver

Bibtex

@article{c7aeac75703e4b94a9179a26a51a0f4b,
title = "Human epithelial stem cell survival within their niche requires {"}tonic{"} cannabinoid receptor 1-signalling-Lessons from the hair follicle",
abstract = "The endocannabinoid system (ECS) regulates multiple aspects of human epithelial physiology, including inhibition/stimulation of keratinocyte proliferation/apoptosis, respectively. Yet, how the ECS impacts on human adult epithelial stem cell (eSC) functions remains unknown. Scalp hair follicles (HFs) offer a clinically relevant, prototypic model system for studying this directly within the native human stem cell niche. Here, we show in organ-cultured human HFs that, unexpectedly, selective activation of cannabinoid receptor-1 (CB1)-mediated signalling via the MAPK (MEK/Erk 1/2) and Akt pathways significantly increases the number and proliferation of cytokeratin CK15+ or CK19+ human HF bulge eSCs in situ, and enhances CK15 promoter activity in situ. In striking contrast, CB1-stimulation promotes apoptosis in the differentiated progeny of these eSCs (CK6+ HF keratinocytes). Instead, intrafollicular CB1 gene knockdown or CB1 antagonist treatment significantly reduces human HF eSCs numbers and stimulates their apoptosis, while CB1 knockout mice exhibit a reduced bulge eSCs pool in vivo. This identifies {"}tonic{"} CB1 signalling as a required survival stimulus for adult human HF eSCs within their niche. This novel concept must be taken into account whenever the human ECS is targeted therapeutically.",
author = "Koji Sugawara and N{\'o}ra Z{\'a}k{\'a}ny and Stephan Tiede and Talveen Purba and Matthew Harries and Daisuke Tsuruta and Tam{\'a}s B{\'i}r{\'o} and Ralf Paus",
note = "This article is protected by copyright. All rights reserved.",
year = "2021",
month = apr,
doi = "10.1111/exd.14294",
language = "English",
volume = "30",
pages = "479--493",
journal = "EXP DERMATOL",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Human epithelial stem cell survival within their niche requires "tonic" cannabinoid receptor 1-signalling-Lessons from the hair follicle

AU - Sugawara, Koji

AU - Zákány, Nóra

AU - Tiede, Stephan

AU - Purba, Talveen

AU - Harries, Matthew

AU - Tsuruta, Daisuke

AU - Bíró, Tamás

AU - Paus, Ralf

N1 - This article is protected by copyright. All rights reserved.

PY - 2021/4

Y1 - 2021/4

N2 - The endocannabinoid system (ECS) regulates multiple aspects of human epithelial physiology, including inhibition/stimulation of keratinocyte proliferation/apoptosis, respectively. Yet, how the ECS impacts on human adult epithelial stem cell (eSC) functions remains unknown. Scalp hair follicles (HFs) offer a clinically relevant, prototypic model system for studying this directly within the native human stem cell niche. Here, we show in organ-cultured human HFs that, unexpectedly, selective activation of cannabinoid receptor-1 (CB1)-mediated signalling via the MAPK (MEK/Erk 1/2) and Akt pathways significantly increases the number and proliferation of cytokeratin CK15+ or CK19+ human HF bulge eSCs in situ, and enhances CK15 promoter activity in situ. In striking contrast, CB1-stimulation promotes apoptosis in the differentiated progeny of these eSCs (CK6+ HF keratinocytes). Instead, intrafollicular CB1 gene knockdown or CB1 antagonist treatment significantly reduces human HF eSCs numbers and stimulates their apoptosis, while CB1 knockout mice exhibit a reduced bulge eSCs pool in vivo. This identifies "tonic" CB1 signalling as a required survival stimulus for adult human HF eSCs within their niche. This novel concept must be taken into account whenever the human ECS is targeted therapeutically.

AB - The endocannabinoid system (ECS) regulates multiple aspects of human epithelial physiology, including inhibition/stimulation of keratinocyte proliferation/apoptosis, respectively. Yet, how the ECS impacts on human adult epithelial stem cell (eSC) functions remains unknown. Scalp hair follicles (HFs) offer a clinically relevant, prototypic model system for studying this directly within the native human stem cell niche. Here, we show in organ-cultured human HFs that, unexpectedly, selective activation of cannabinoid receptor-1 (CB1)-mediated signalling via the MAPK (MEK/Erk 1/2) and Akt pathways significantly increases the number and proliferation of cytokeratin CK15+ or CK19+ human HF bulge eSCs in situ, and enhances CK15 promoter activity in situ. In striking contrast, CB1-stimulation promotes apoptosis in the differentiated progeny of these eSCs (CK6+ HF keratinocytes). Instead, intrafollicular CB1 gene knockdown or CB1 antagonist treatment significantly reduces human HF eSCs numbers and stimulates their apoptosis, while CB1 knockout mice exhibit a reduced bulge eSCs pool in vivo. This identifies "tonic" CB1 signalling as a required survival stimulus for adult human HF eSCs within their niche. This novel concept must be taken into account whenever the human ECS is targeted therapeutically.

U2 - 10.1111/exd.14294

DO - 10.1111/exd.14294

M3 - SCORING: Journal article

C2 - 33523535

VL - 30

SP - 479

EP - 493

JO - EXP DERMATOL

JF - EXP DERMATOL

SN - 0906-6705

IS - 4

ER -